Preclinical atherosclerotic changes(endothelial dysfunction and carotidartery wall thickening)Disease severity positively correlateswith amount of subset presentPre-disposition to extra-articularinflammatory lesionsInfliximab reduces CD4+CD28− T cells. This evidence concerns the gene CD28 and endothelial dysfunction.